U.S. markets closed
  • S&P Futures

    4,214.00
    +4.25 (+0.10%)
     
  • Dow Futures

    33,329.00
    +25.00 (+0.08%)
     
  • Nasdaq Futures

    13,332.25
    +21.00 (+0.16%)
     
  • Russell 2000 Futures

    1,978.40
    +2.10 (+0.11%)
     
  • Crude Oil

    94.00
    -0.34 (-0.36%)
     
  • Gold

    1,804.40
    -2.80 (-0.15%)
     
  • Silver

    20.23
    -0.12 (-0.61%)
     
  • EUR/USD

    1.0324
    -0.0001 (-0.01%)
     
  • 10-Yr Bond

    2.8880
    +0.1020 (+3.66%)
     
  • Vix

    20.20
    +0.46 (+2.33%)
     
  • GBP/USD

    1.2196
    -0.0007 (-0.06%)
     
  • USD/JPY

    133.0300
    +0.0310 (+0.02%)
     
  • BTC-USD

    23,957.20
    +8.86 (+0.04%)
     
  • CMC Crypto 200

    568.09
    -6.65 (-1.16%)
     
  • FTSE 100

    7,465.91
    -41.20 (-0.55%)
     
  • Nikkei 225

    27,819.33
    -180.63 (-0.65%)
     

How Newcomer Arcellx Is Looking To Rival Johnson & Johnson In Cancer

·2 min read
How Newcomer Arcellx Is Looking To Rival Johnson & Johnson In Cancer
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Newcomer Arcellx could rival Johnson & Johnson in multiple myeloma, an analyst said as the biotech popped to a two-month high.